Literature DB >> 19228488

Pulmonary arterial hypertension.

Aydin Uzunpinar1, Mehmet Cilingiroglu.   

Abstract

Pulmonary arterial hypertension is a progressive disease of pulmonary vasculature characterized by increased mean pulmonary arterial pressure and elevated vascular resistance with normal left-sided pressures, differentiating it from left-sided heart disease. The pathogenesis involves thrombosis, vasoconstriction, and remodeling of small pulmonary arteries. It presents with common symptoms such as shortness of breath, chest pain, and decreased exercise tolerance. Left untreated, progressive increase in right ventricular overload leads to right heart failure and death. Over the course of the past decade, better understanding of the pathogenesis and an increasing number of treatment options have resulted in improved prognosis and quality of life.

Entities:  

Mesh:

Year:  2009        PMID: 19228488     DOI: 10.1007/s11883-009-0022-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  42 in total

1.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

2.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

3.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

4.  Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Authors:  Kelly M Chin; Richard N Channick; Lewis J Rubin
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

Review 5.  Primary pulmonary hypertension.

Authors:  S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

6.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 7.  Diagnosis and differential assessment of pulmonary arterial hypertension.

Authors:  Robyn J Barst; Michael McGoon; Adam Torbicki; Olivier Sitbon; Michael J Krowka; Horst Olschewski; Sean Gaine
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

Review 8.  Genetic basis of pulmonary arterial hypertension: current understanding and future directions.

Authors:  John H Newman; Richard C Trembath; Jane A Morse; Ekkehard Grunig; James E Loyd; Serge Adnot; Fabio Coccolo; Carlo Ventura; John A Phillips; James A Knowles; Bart Janssen; Oliver Eickelberg; Saadia Eddahibi; Phillipe Herve; William C Nichols; Gregory Elliott
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

9.  Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.

Authors:  Elisabeth Marcos; Elie Fadel; Olivier Sanchez; Marc Humbert; Philippe Dartevelle; Gerald Simonneau; Michel Hamon; Serge Adnot; Saadia Eddahibi
Journal:  Circ Res       Date:  2004-04-01       Impact factor: 17.367

10.  Inhaled iloprost for severe pulmonary hypertension.

Authors:  Horst Olschewski; Gerald Simonneau; Nazzareno Galiè; Timothy Higenbottam; Robert Naeije; Lewis J Rubin; Sylvia Nikkho; Rudolf Speich; Marius M Hoeper; Jürgen Behr; Jörg Winkler; Olivier Sitbon; Wladimir Popov; H Ardeschir Ghofrani; Alessandra Manes; David G Kiely; Ralph Ewert; Andreas Meyer; Paul A Corris; Marion Delcroix; Miguel Gomez-Sanchez; Harald Siedentop; Werner Seeger
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  2 in total

1.  Silencing of STIM1 attenuates hypoxia-induced PASMCs proliferation via inhibition of the SOC/Ca2+/NFAT pathway.

Authors:  Xianhua Hou; Jian Chen; Yongjun Luo; Fuyu Liu; Gang Xu; Yuqi Gao
Journal:  Respir Res       Date:  2013-01-05

2.  TNM-like classification: a new proposed method for heart failure staging.

Authors:  Francesco Fedele; Maria Chiara Gatto; Alessandra D'Ambrosi; Massimo Mancone
Journal:  ScientificWorldJournal       Date:  2013-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.